Peritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis
ASM Case Reports · 29.10.2026
DOI: 10.1128/asmcr.00118-26 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASM Case Reports, online erschienen am 29.10.2026. Verfasst von Gabriele Arcari und 10 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Peritoneal dialysis (PD)-associated peritonitis is a major cause of hospitalization, catheter loss, and technique failure. Ochrobactrum anthropi is an environmental, low-virulence, non-fermenting gram-negative bacillus that may cause device-associated infections and exhibits intrinsic beta-lactam resistance mediated by the chromosomal beta-lactamase bla OCH . Case Summary A young adult with Bardet-Biedl syndrome receiving long-term PD presented with cloudy effluent, marked peritoneal leukocytosis, and minimal systemic symptoms. Empirical intraperitoneal cefazolin plus ceftazidime was initiated. Repeated peritoneal-fluid cultures yielded O. anthropi , whereas peripheral blood cultures remained negative. Susceptibility testing showed high MICs for beta-lactam/beta-lactamase inhibitor combinations and preserved carbapenem activity. Intravenous meropenem produced partial clinical improvement; however, fever and cloudy effluent recurred after treatment, requiring catheter removal. A new catheter was inserted 1 month later without recurrence.Whole-genome sequencing (WGS) was performed on the O. anthropi isolate recovered on day 11, the second culture-positive peritoneal-fluid sample, generating a 5.31-Mb draft genome used to confirm species assignment and identify resistance genes. The isolate carried a chromosomal ampR-ampC module encoding a novel OCH beta-lactamase variant, designated OCH-17.
Conclusion
This case highlights O. anthropi as a device-associated PD pathogen and illustrates the importance of source control when infection persists despite targeted antimicrobial therapy. WGS supported species identification and characterized a novel chromosomal OCH variant.
Zitieren
APA
Arcari, G., Gigante, P., Avella, A., Nava, E., Caleca, D., Capuano, R., Carbotti, M., Novazzi, F., Jovane, C., Ambrosini, A., & Mancini, N. (2026). Peritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis. ASM Case Reports. https://doi.org/10.1128/asmcr.00118-26
Vancouver
Arcari G, Gigante P, Avella A, Nava E, Caleca D, Capuano R, et al. Peritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis. ASM Case Reports. 2026. doi:10.1128/asmcr.00118-26
BibTeX
@article{Arcari2026,
author = {Arcari, Gabriele and Gigante, Paolo and Avella, Alessandro and Nava, Elisa and Caleca, Domenico and Capuano, Riccardo and Carbotti, Mattia and Novazzi, Federica and Jovane, Carlo and Ambrosini, Andrea and Mancini, Nicasio},
title = {Peritoneal infection due to Ochrobactrum anthropi producing a novel OCH beta-lactamase variant in a patient on peritoneal dialysis: case report and genomic analysis},
journal = {ASM Case Reports},
year = {2026},
doi = {10.1128/asmcr.00118-26}
}
EUVIMED